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Background: Statin therapy, a lipophilic statin Pitavastatin (Livalo) in acute myocardial infarction (AMI) setting may play an important role by not 
only reducing LDL-cholesterol, but also through the pleiotrophic effects, especially in diabetic patients (pts).
Method: This study consisted of 802 consecutive AMI pts underwent percutaneous coronary intervention (PCI) at 10 major centers in Korea. 
Pitavastatin 2mg/day was administered from the AMI presentation time. We investigated whether there are differences in 6 months angiographic and 
12 months clinical outcomes between the diabetic and non-diabetic pts.
Results: A total 699 pts (87.1%) were finished 12-month clinical follow up. The baseline clinical characteristics were not similar between the two 
groups that diabetes group had more elderly, hypertension, previous PCI, multi-vessel disease, left main lesion and lower LV ejection fraction. At 
6 months, angiographic outcomes were similar between the two groups. At 12 months, total death, repeat PCI, TVR-major adverse cardiac events 
(MACE), and total MACE were higher in the diabetes group in univariate analysis. However, after baseline adjustment by multivariate analysis, 
diabetes was an independent predictor of TVR-MACE (OR 2.042, 95% CI 1.063-3.924, p=0.032).
Conclusion: Despite of worse clinical and procedural characteristics in diabetes group, major clinical outcomes were similar with those of non-
diabetes group except higher incidence of TVR-MACE in the diabetes group.
 
